Overview

Perindopril Amlodipine for the Treatment of Hypertension

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of a fixed-dose combination drug compared to two other drugs (monotherapies) in controlling hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Symplmed Pharmaceuticals LLC
Treatments:
Amlodipine
Perindopril